Sexual Dimorphism in Autoimmune Disease
Overview
Authors
Affiliations
We briefly survey the concept of autoimmunity and nominate the range of autoimmune diseases that include multisystemic and organ-specific disorders, and cite prevalences of autoimmune diseases in males and females, in humans and in experimental animals. Most human autoimmune diseases such as systemic lupus erythematosus (SLE), multiple sclerosis (MS) and autoimmune thyroid disease, have an increased incidence and prevalence in females, but a few others such as autoimmune diabetes, the Guillain Barré syndrome (GBS) and psoriasis are increased in males. Animal models of autoimmunity show an equivalent sexual dimorphism. The possible reasons for the differing incidence and prevalence of autoimmune diseases in females and males engage our attention. Environmental exposures may differ for females and males. There are innate differences in the function of the female and male immune systems, and there is some evidence for differences between females and males in the ability of a target organ for autoimmunity to withstand damage. In seeking reasons for these differences, we review the role of sex hormones in immunity and include results of trials of hormone therapy in autoimmune diseases. The association of autoimmunity and pregnancy, a female-specific condition, is discussed, and the claimed effects of lymphoid cell microchimerism on provocation of autoimmunity are reviewed. Genetic predisposition is an important factor in autoimmune disease and we particularly focus on genes on the X and Y chromosomes, the role of X chromosome inactivation, and the interaction of the sex of the patient with other genetic factors. The possible role of epigenetic mechanisms, including environmental influences, is then surveyed. We assert that sex is a vital variable that must be considered in all immunological studies, as it should be at all levels of biological research.
Sex hormones and allergies: exploring the gender differences in immune responses.
Gutierrez-Brito J, Lomeli-Nieto J, Munoz-Valle J, Oregon-Romero E, Corona-Angeles J, Hernandez-Bello J Front Allergy. 2025; 5():1483919.
PMID: 39840271 PMC: 11747284. DOI: 10.3389/falgy.2024.1483919.
Pagaling G, Dichoso L, Reyes N, Prado Jr M BMC Neurol. 2025; 25(1):29.
PMID: 39838311 PMC: 11748846. DOI: 10.1186/s12883-025-04029-3.
Paternal impact on the developmental programming of sexual dimorphism.
Aljabali S, Pai S, Teperino R Front Cell Dev Biol. 2024; 12:1520783.
PMID: 39712575 PMC: 11659275. DOI: 10.3389/fcell.2024.1520783.
Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry.
Vohanka S, Tichopad A, Horakova M, Junkerova J, Jakubikova M, Pitha J Neurol Ther. 2024; 14(1):227-242.
PMID: 39630385 PMC: 11762035. DOI: 10.1007/s40120-024-00682-x.
Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis.
Jacob S, Lee S, Kim S, Sharkey K, Pfeffer G, Nguyen M Nat Rev Neurol. 2024; 20(8):475-494.
PMID: 38965379 DOI: 10.1038/s41582-024-00991-7.